Research Paper Volume 13, Issue 9 pp 12849—12864

The prognostic and immunological effects of ZBTB7C across cancers: friend or foe?

Survival analysis of ZBTB7C in different tumors. OS and Cox regression analyses of (A, E) colon adenocarcinoma (COAD), (B, F) lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), (C, G) esophageal carcinoma (ESCA) and (D, H) mesothelioma (MESO). OS, overall survival.

Figure 2. Survival analysis of ZBTB7C in different tumors. OS and Cox regression analyses of (A, E) colon adenocarcinoma (COAD), (B, F) lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), (C, G) esophageal carcinoma (ESCA) and (D, H) mesothelioma (MESO). OS, overall survival.